Recent clinical studies have found that exenatide therapy was found to induce long-lasting improvements in motor and cognitive function in patients with Parkinsons disease
Boosting GIPR activity could directly affect the myocardium and indirectly influence cardiovascular function and outcomes through its systemic effects on other organs [13]
This medication has become a popular choice for those looking to achieve significant weight loss by regulating appetite and blood sugar levels
Tirzepatide treatment was also associated with a reduction in waist circumference, systolic blood pressure, fasting insulin and plasma lipid concentrations as cardiometabolic risk parameters
Efficacy and safety of once-weekly dulaglutide versus insulin glargine in patients with type 2 Diabetes on metformin and glimepiride (AWARD-2)
Regina DePietro, MD, a family medicine physician at MU Health Care in Columbia, Missouri, says that people also may microdose GLP-1s if they only want to lose a small amount of weight